Current Research Studies
-
A back to top
-
- ADHD – Lifestyle Enhancement for ADHD Program (LEAP)
- ADHD – The Effects of ADHD Medicine (TEAM) Study
- Asthma – Airway Epithelial Cell Cytokine Profiles of Children With and Without Asthma Study
- Autism – SPARK: Simons Foundation Powering Autism Research for Knowledge Study
- Autism – The Autism Biomarkers Consortium Clinical Trials
-
C back to top
-
- Cancer – A Phase 2 Study Evaluating Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors for Prevention of GVHD
- Cancer – ACNS0831: Phase 3 Randomized Trial of Post-Radiation Chemotherapy in Patients with Newly Diagnosed Ependymoma Ages 1 to 21 Years
- Cancer – ACNS1422: Phase 2 Study of Reduced Therapy for Newly Diagnosed Average-Risk WNT-Driven Medulloblastoma Patients
- Cancer – BrainChild-01: CAR T-Cell Therapy for Brain and Central Nervous System Tumors Clinical Trial
- Cancer – BrainChild-02: Phase 1 Study of EGFR806-Specific CAR T-Cell Locoregional Immunotherapy for EGFR-Positive Recurrent or Refractory Pediatric Central Nervous System Tumors
- Cancer – ENCIT-01: Engineered Neuroblastoma Cellular Immunotherapy
- Cancer – HA-1 TCR T-Cell Immunotherapy for Treating Patients with Relapsed or Refractory Acute Leukemia after Donor Stem Cell Transplant Clinical Trial
- Cancer – PBTC-042: Phase I Study of CDK 4-6 Inhibitor PD-0332991 In Children With Recurrent, Progressive or Refractory Central Nervous System Tumors
- Cancer – PLAT-02: A Phase 1/2 Feasibility and Safety Study of CD19-CAR T-Cell Immunotherapy for CD19+ Leukemia
- Cancer – PLAT-03: A Pilot Feasibility and Safety Study of CD19t T-APC Vaccination Following CAR T-Cell Immunotherapy for CD19+ Leukemia
- Cancer – PLAT-04: A Phase 1 Feasibility and Safety Study of CD22 CAR T-Cell Immunotherapy for CD22+ Leukemia
- Cancer – PLAT-05: A Phase 1 Feasibility and Safety Study of Dual Specificity CD19 and CD22-CAR T-Cell Immunotherapy for CD19+CD22+ Leukemia and Lymphoma
- Cancer – PLAT-06: A Phase 1/2 Study of CD19-specific CAR T Cells With a Fully Human Binding Domain for CD19+ Leukemia or Lymphoma
- Cancer – PNOC012: A Randomized, Blinded Study of Fluorescence Detection of Pediatric Primary Central Nervous System Tumors in Subjects Receiving Tozuleristide and Imaged With the Canvas System
- Cancer – SC-4016: Phase 1 and 2 Study of LOXO-195 in Patients With Previously Treated NTRK Fusion Cancers
- Cancer – SC-9010: Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors (SJATRT)
- Cancer – SC-9012: Phase I-II Study of MEK 162 for Children with Low-Grade Gliomas and Other Ras/Raf/ERK Pathway Activated Tumors
- Cancer – STRIvE-01: Phase I Study of EGFR806 CAR T Cell Immunotherapy for Relapsed or Refractory Solid Tumors in Children and Young Adults
- Cleft Lip and Palate – A Retrospective Study of Breast Milk Feeding Children with Oral Clefts
- Cleft Lip and Palate – Clinical Effectiveness of Late Maxillary Protraction in Cleft Lip and Palate Study
- Cleft Lip and Palate – Infants with Orofacial Clefts: Development and Validation of an Observer-Reported Outcomes Instrument (ICOO)
- Concussion – Collaborative Care Model for Treatment of Persistent Symptoms After Concussion Among Youth (Collaborative Care Study)
- Cystic Fibrosis – STOP-PEDS Feasibility: Standardizing Treatment of Pulmonary Exacerbations in Pediatrics Pilot Feasibility Study
-
D back to top
-
G back to top
-
H back to top
-
K back to top
-
P back to top
-
S back to top
-
- Sleep – Sleep and Ecological Factors in Infants with Craniofacial Conditions (ECOSleep) Study
- Sleep – Sleep Health in Preschoolers (SHIP)
- Spina Bifida – Evaluation of Best Urologic Management for Newborns and Young Children with Spina Bifida Study
- Spina Bifida – National Spina Bifida Patient Registry
-
W back to top